{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:39:39Z","timestamp":1792589979223,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s12035-008-8020-5","type":"journal-article","created":{"date-parts":[[2008,5,5]],"date-time":"2008-05-05T17:55:30Z","timestamp":1210010130000},"page":"83-90","source":"Crossref","is-referenced-by-count":130,"title":["Molecular Mechanisms of Sensitization of Pain-transducing P2X3 Receptors by the Migraine Mediators CGRP and NGF"],"prefix":"10.1007","volume":"37","author":[{"given":"Rashid","family":"Giniatullin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Nistri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Fabbretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,6]]},"reference":[{"key":"8020_CR1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","volume":"87","author":"G Burnstock","year":"2007","unstructured":"Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659\u2013797","journal-title":"Physiol Rev"},{"key":"8020_CR2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature04886","volume":"442","author":"BS Khakh","year":"2006","unstructured":"Khakh BS, North RA (2006) P2X receptors as cell-surface ATP sensors in health and disease. Nature 442:527\u2013532","journal-title":"Nature"},{"key":"8020_CR3","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1460-9568.2005.03976.x","volume":"21","author":"S Grishin","year":"2005","unstructured":"Grishin S, Shakirzyanova A, Giniatullin A, Afzalov R, Giniatullin R (2005) Mechanisms of ATP action on motor nerve terminals at the frog neuromuscular junction. Eur J Neurosci 21:1271\u20131279","journal-title":"Eur J Neurosci"},{"key":"8020_CR4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1471-4159.2007.04824.x","volume":"102","author":"K Inoue","year":"2007","unstructured":"Inoue K, Koizumi S, Tsuda M (2007) The role of nucleotides in the neuron\u2013glia communication responsible for the brain functions. J Neurochem 102:1447\u20131458","journal-title":"J Neurochem"},{"key":"8020_CR5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tips.2007.07.002","volume":"28","author":"F Virgilio Di","year":"2007","unstructured":"Di Virgilio F (2007) Liaisons dangereuses: P2X7 and the inflammasome. Trends Pharmacol Sci 28:465\u2013472","journal-title":"Trends Pharmacol Sci"},{"key":"8020_CR6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0031-6997(24)01512-6","volume":"53","author":"BA Chizh","year":"2001","unstructured":"Chizh BA, Illes P (2001) P2X receptors and nociception. Pharmacol Rev 53:553\u2013568","journal-title":"Pharmacol Rev"},{"key":"8020_CR7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1113\/jphysiol.2003.048587","volume":"554","author":"RA North","year":"2004","unstructured":"North RA (2004) P2X3 receptors and peripheral pain mechanisms. J Physiol 554:301\u2013308","journal-title":"J Physiol"},{"key":"8020_CR8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12035-007-0033-y","volume":"36","author":"K Wirkner","year":"2007","unstructured":"Wirkner K, Sperlagh B, Illes P (2007) P2X3 receptor involvement in pain states. Mol Neurobiol 36:165\u2013183","journal-title":"Mol Neurobiol"},{"key":"8020_CR9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1517\/14728222.7.4.513","volume":"7","author":"MF Jarvis","year":"2003","unstructured":"Jarvis MF (2003) Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain. Expert Opin Ther Targets 7:513\u2013522","journal-title":"Expert Opin Ther Targets"},{"key":"8020_CR10","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1523\/JNEUROSCI.22-18-08139.2002","volume":"22","author":"J Barclay","year":"2002","unstructured":"Barclay J, Patel S, Dorn G, Wotherspoon G, Moffatt S, Eunson L, Abdel\u2019al S, Natt F, Hall J, Winter J, Bevan S, Wishart W, Fox A, Ganju P (2002) Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. J Neurosci 22:8139\u20138147","journal-title":"J Neurosci"},{"key":"8020_CR11","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1093\/nar\/gnh044","volume":"32","author":"G Dorn","year":"2004","unstructured":"Dorn G, Patel S, Wotherspoon G, Hemmings-Mieszczak M, Barclay J, Natt FJ, Martin P, Bevan S, Fox A, Ganju P, Wishart W, Hall J (2004) siRNA relieves chronic neuropathic pain. Nucleic Acids Res 32:e49","journal-title":"Nucleic Acids Res"},{"key":"8020_CR12","first-page":"833","volume":"4","author":"RA North","year":"2003","unstructured":"North RA (2003) The P2X3 subunit: a molecular target in pain therapeutics. Curr Opin Investig Drugs 4:833\u2013840","journal-title":"Curr Opin Investig Drugs"},{"key":"8020_CR13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/35039519","volume":"407","author":"DA Cockayne","year":"2000","unstructured":"Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, Hedley L, Lachnit WG, Burnstock G, McMahon SB, Ford AP (2000) Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407:1011\u20131015","journal-title":"Nature"},{"key":"8020_CR14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/35039526","volume":"407","author":"V Souslova","year":"2000","unstructured":"Souslova V, Cesare P, Ding Y, Akopian AN, Stanfa L, Suzuki R, Carpenter K, Dickenson A, Boyce S, Hill R, Nebenuis-Oosthuizen D, Smith AJ, Kidd EJ, Wood JN (2000) Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature 407:1015\u20131017","journal-title":"Nature"},{"key":"8020_CR15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1113\/jphysiol.2005.088435","volume":"567","author":"DA Cockayne","year":"2005","unstructured":"Cockayne DA, Dunn PM, Zhong Y, Rong W, Hamilton SG, Knight GE, Ruan HZ, Ma B, Yip P, Nunn P, McMahon SB, Burnstock G, Ford AP (2005) P2X2 knockout mice and P2X2\/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J Physiol 567:621\u2013639","journal-title":"J Physiol"},{"key":"8020_CR16","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1523\/JNEUROSCI.18-22-09238.1998","volume":"18","author":"SP Cook","year":"1998","unstructured":"Cook SP, Rodland KD, McCleskey EW (1998) A memory for extracellular Ca2+ by speeding recovery of P2X receptors from desensitization. J Neurosci 18:9238\u20139244","journal-title":"J Neurosci"},{"key":"8020_CR17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/sj.bjp.0705701","volume":"141","author":"E Sokolova","year":"2004","unstructured":"Sokolova E, Skorinkin A, Fabbretti E, Masten L, Nistri A, Giniatullin R (2004) Agonist-dependence of recovery from desensitization of P2X3 receptors provides a novel and sensitive approach for their rapid up or down regulation. Br J Pharmacol 141:1048\u20131058","journal-title":"Br J Pharmacol"},{"key":"8020_CR18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1124\/mol.106.023564","volume":"70","author":"E Sokolova","year":"2006","unstructured":"Sokolova E, Skorinkin A, Moiseev I, Agrachev A, Nistri A, Giniatullin R (2006) Experimental and modeling studies of desensitization of P2X3 receptors. Molec Pharm 70:373\u2013382","journal-title":"Molec Pharm"},{"key":"8020_CR19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1358\/dnp.2005.18.8.942082","volume":"18","author":"S McGaraughty","year":"2005","unstructured":"McGaraughty S, Jarvis MF (2005) Antinociceptive properties of a non-nucleotide P2X3\/P2X2\/3 receptor antagonist. Drug News Perspect 18:501\u2013507","journal-title":"Drug News Perspect"},{"key":"8020_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.pharmthera.2005.08.013","volume":"110","author":"G Burnstock","year":"2006","unstructured":"Burnstock G (2006) Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther 110:433\u2013454","journal-title":"Pharmacol Ther"},{"key":"8020_CR21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2005.12.001","volume":"27","author":"FF Hefti","year":"2002","unstructured":"Hefti FF, Rosenthal A, Walicke PA, Wyatt S, Vergara G, Shelton DL, Davies AM (2002) Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol Sci 27:85\u201391","journal-title":"Trends Pharmacol Sci"},{"key":"8020_CR22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrn1102","volume":"4","author":"D Pietrobon","year":"2003","unstructured":"Pietrobon D, Striessnig J (2003) Neurobiology of migraine. Nat Rev Neurosci 4:386\u2013398","journal-title":"Nat Rev Neurosci"},{"key":"8020_CR23","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1152\/jn.01293.2005","volume":"95","author":"AM Strassman","year":"2006","unstructured":"Strassman AM, Levy D (2006) Response properties of dural nociceptors in relation to headache. J Neurophysiol 95:1298\u20131306","journal-title":"J Neurophysiol"},{"key":"8020_CR24","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.64.10_suppl_2.S9","volume":"64","author":"C Waeber","year":"2005","unstructured":"Waeber C, Moskowitz MA (2005) Migraine as an inflammatory disorder. Neurology 64:S9\u201315","journal-title":"Neurology"},{"issue":"Suppl 1","key":"8020_CR25","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1111\/j.1526-4610.2006.00485.x","volume":"46","author":"D Levy","year":"2006","unstructured":"Levy D, Burstein R, Strassman AM (2006) Mast cell involvement in the pathophysiology of migraine headache: an hypothesis. Headache 46(Suppl 1):S13\u2013S18","journal-title":"Headache"},{"key":"8020_CR26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.molmed.2006.11.005","volume":"13","author":"PJ Goadsby","year":"2007","unstructured":"Goadsby PJ (2007) Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 13:39\u201344","journal-title":"Trends Mol Med"},{"key":"8020_CR27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1476-5381.1995.tb13361.x","volume":"114","author":"M Kurosawa","year":"1995","unstructured":"Kurosawa M, Messlinger K, Pawlak M, Schmidt RF (1995) Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br J Pharmacol 114:1397\u2013402","journal-title":"Br J Pharmacol"},{"key":"8020_CR28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/384560a0","volume":"384","author":"AM Strassman","year":"1996","unstructured":"Strassman AM, Raymond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384:560\u2013564","journal-title":"Nature"},{"key":"8020_CR29","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1152\/jn.00029.2002","volume":"88","author":"D Levy","year":"2002","unstructured":"Levy D, Strassman AM (2002) Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura. J Neurophysiol 88:3021\u20133031","journal-title":"J Neurophysiol"},{"key":"8020_CR30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1139\/y95-143","volume":"73","author":"K Messlinger","year":"1995","unstructured":"Messlinger K, Hanesch U, Kurosawa M, Pawlak M, Schmidt RF (1995) Calcitonin gene related peptide released from dural nerve fibers mediates increase of meningeal blood flow in the rat. Can J Physiol Pharmacol 73:1020\u20131024","journal-title":"Can J Physiol Pharmacol"},{"key":"8020_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.57.1.132","volume":"57","author":"P Sarchielli","year":"2001","unstructured":"Sarchielli P, Alberti A, Floridi A, Gallai V (2001) Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology 57:132\u2013134","journal-title":"Neurology"},{"key":"8020_CR32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1586\/14737175.4.1.115","volume":"4","author":"P Sarchielli","year":"2004","unstructured":"Sarchielli P, Gallai V (2004) Nerve growth factor and chronic daily headache: a potential implication for therapy. Expert Rev Neurother 4:115\u2013127","journal-title":"Expert Rev Neurother"},{"key":"8020_CR33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1468-2982.2005.01006.x","volume":"26","author":"F Blandini","year":"2006","unstructured":"Blandini F, Rinaldi L, Tassorelli C, Sances G, Motta M, Samuele A, Fancellu R, Nappi G, Leon A (2006) Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia 26:136\u2013142","journal-title":"Cephalalgia"},{"key":"8020_CR34","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1523\/JNEUROSCI.0647-06.2006","volume":"26","author":"E Fabbretti","year":"2006","unstructured":"Fabbretti E, D\u2019Arco M, Fabbro A, Simonetti M, Nistri A, Giniatullin R (2006) Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide. J Neurosci 26:6163\u20136171","journal-title":"J Neurosci"},{"key":"8020_CR35","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1523\/JNEUROSCI.4542-06.2007","volume":"27","author":"Z Zhang","year":"2007","unstructured":"Zhang Z, Winborn CS, Marquez de Prado B, Russo AF (2007) Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 27:2693\u20132703","journal-title":"J Neurosci"},{"key":"8020_CR36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","volume":"54","author":"DR Poyner","year":"2002","unstructured":"Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54:233\u2013246","journal-title":"Pharmacol Rev"},{"key":"8020_CR37","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1471-4159.2006.04161.x","volume":"99","author":"I Buldyrev","year":"2006","unstructured":"Buldyrev I, Tanner NM, Hsieh HY, Dodd EG, Nguyen LT, Balkowiec A (2006) Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons. J Neurochem 99:1338\u20131350","journal-title":"J Neurochem"},{"key":"8020_CR38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ana.20619","volume":"58","author":"D Levy","year":"2005","unstructured":"Levy D, Burstein R, Strassman AM (2005) Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol 58:698\u2013705","journal-title":"Ann Neurol"},{"key":"8020_CR39","doi-asserted-by":"crossref","first-page":"8190","DOI":"10.1523\/JNEUROSCI.0713-07.2007","volume":"27","author":"M D\u2019Arco","year":"2007","unstructured":"D\u2019Arco M, Giniatullin R, Simonetti M, Fabbro A, Nair A, Nistri A, Fabbretti E (2007) Neutralization of nerve growth factor induces plasticity of ATP-sensitive P2X3 receptors of nociceptive trigeminal ganglion neurons. J Neurosci 27:8190\u20138201","journal-title":"J Neurosci"},{"key":"8020_CR40","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bjp.0705337","volume":"139","author":"S Angelantonio Di","year":"2003","unstructured":"Di Angelantonio S, Giniatullin R, Costa V, Sokolova E, Nistri A (2003) Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells. Br J Pharmacol 139:1061\u20131073","journal-title":"Br J Pharmacol"},{"key":"8020_CR41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/JMN:22:1-2:105","volume":"22","author":"DL Hay","year":"2004","unstructured":"Hay DL, Conner AC, Howitt SG, Smith DM, Poyner DR (2004) The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. J Mol Neurosci 22:105\u2013113","journal-title":"J Mol Neurosci"},{"key":"8020_CR42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0306-4522(98)00366-2","volume":"89","author":"A Ebersberger","year":"1999","unstructured":"Ebersberger A, Averbeck B, Messlinger K, Reeh PW (1999) Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 89:901\u2013907","journal-title":"Neuroscience"},{"key":"8020_CR43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/bmj.332.7532.25","volume":"332","author":"PJ Goadsby","year":"2006","unstructured":"Goadsby PJ (2006) Recent advances in the diagnosis and management of migraine. BMJ 332:25\u201329","journal-title":"BMJ"},{"key":"8020_CR44","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1523\/JNEUROSCI.23-03-00807.2003","volume":"23","author":"PL Durham","year":"2003","unstructured":"Durham PL, Russo AF (2003) Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci 23:807\u2013815","journal-title":"J Neurosci"},{"key":"8020_CR45","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/cne.21607","volume":"507","author":"JK Lennerz","year":"2008","unstructured":"Lennerz JK, R\u00fchle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, Messlinger K (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277\u20131299","journal-title":"J Comp Neurol"},{"key":"8020_CR46","doi-asserted-by":"crossref","unstructured":"Simonetti M, Giniatullin R, Fabbretti E (2008) Mechanisms mediating the enhanced transcription of the P2X3 receptor gene by calcitonin gene related peptide in trigeminal sensory neurons. J Biol Chem (submitted)","DOI":"10.1074\/jbc.M800296200"},{"key":"8020_CR47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35093019","volume":"413","author":"D Julius","year":"2001","unstructured":"Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413:203\u2013210","journal-title":"Nature"},{"key":"8020_CR48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3940(02)00741-3","volume":"330","author":"M Hou","year":"2002","unstructured":"Hou M, Uddman R, Tajti J, Kanje M, Edvinsson L (2002) Capsaicin receptor immunoreactivity in the human trigeminal ganglion. Neurosci Lett 330:223\u2013226","journal-title":"Neurosci Lett"},{"key":"8020_CR49","first-page":"2","volume":"28","author":"M Simonetti","year":"2006","unstructured":"Simonetti M, Fabbro A, D\u2019Arco M, Zweyer M, Nistri A, Giniatullin R, Fabbretti E (2006) Comparison of P2X and TRPV1 receptors in ganglia or primary culture of trigeminal neurons and their modulation by NGF or serotonin. Mol Pain 28:2\u201311","journal-title":"Mol Pain"},{"key":"8020_CR50","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pain.2005.04.002","volume":"116","author":"G Natura","year":"2005","unstructured":"Natura G, von Banchet GS, Schaible HG (2005) Calcitonin gene-related peptide enhances TTX-resistant sodium currents in cultured dorsal root ganglion neurons from adult rats. Pain 116:194\u2013204","journal-title":"Pain"},{"key":"8020_CR51","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1046\/j.1471-4159.2001.00288.x","volume":"77","author":"MS Ramer","year":"2001","unstructured":"Ramer MS, Bradbury EJ, McMahon SB (2001) Nerve growth factor induces P2X3 expression in sensory neurons. J Neurochem 77:864\u2013875","journal-title":"J Neurochem"},{"key":"8020_CR52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1113\/jphysiol.2003.039990","volume":"551","author":"JK Bonnington","year":"2003","unstructured":"Bonnington JK, McNaughton PA (2003) Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol 551:433\u2013446","journal-title":"J Physiol"},{"key":"8020_CR53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.neuro.29.051605.112929","volume":"29","author":"S Pezet","year":"2006","unstructured":"Pezet S, McMahon SB (2006) Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 29:507\u2013538","journal-title":"Annu Rev Neurosci"},{"key":"8020_CR54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj3450233","volume":"345","author":"K Freeland","year":"2000","unstructured":"Freeland K, Liu YZ, Latchman DS (2000) Distinct signalling pathways mediate the cAMP response element (CRE)-dependent activation of the calcitonin gene-related peptide gene promoter by cAMP and nerve growth factor. Biochem J 345:233\u2013238","journal-title":"Biochem J"},{"key":"8020_CR55","doi-asserted-by":"crossref","first-page":"10190","DOI":"10.1074\/jbc.275.14.10190","volume":"275","author":"E Boue-Grabot","year":"2000","unstructured":"Boue-Grabot E, Archambault V, Seguela PA (2000) Protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X2 ATP-gated channels. J Biol Chem 275:10190\u201310195","journal-title":"J Biol Chem"},{"key":"8020_CR56","doi-asserted-by":"crossref","first-page":"21077","DOI":"10.1074\/jbc.M101465200","volume":"276","author":"M Paukert","year":"2001","unstructured":"Paukert M, Osteroth R, Geisler HS, Brandle U, Glowatzki E, Ruppersberg JP, Grunder S (2001) Inflammatory mediators potentiate ATP-gated channels through the P2X3 subunit. J Biol Chem 276:21077\u201321082","journal-title":"J Biol Chem"},{"key":"8020_CR57","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1523\/JNEUROSCI.23-26-08903.2003","volume":"23","author":"LH Jiang","year":"2003","unstructured":"Jiang LH, Kim M, Spelta V, Bo X, Surprenant A, North RA (2003) Subunit arrangement in P2X receptors. J Neurosci 23:8903\u20138910","journal-title":"J Neurosci"},{"key":"8020_CR58","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1124\/mol.105.019802","volume":"69","author":"TA Koshimizu","year":"2006","unstructured":"Koshimizu TA, Kretschmannova K, He ML, Ueno S, Tanoue A, Yanagihara N, Stojilkovic SS, Tsujimoto G (2006) Carboxyl-terminal splicing enhances physical interactions between the cytoplasmic tails of purinergic P2X receptors. Mol Pharmacol 69:1588\u20131598","journal-title":"Mol Pharmacol"},{"key":"8020_CR59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1254\/jphs.CPJ06012X","volume":"101","author":"TA Koshimizu","year":"2006","unstructured":"Koshimizu TA, Tsujimoto G (2006) Functional role of spliced cytoplasmic tails in P2X2-receptor-mediated cellular signaling. J Pharmacol Sci 101:261\u2013266","journal-title":"J Pharmacol Sci"},{"key":"8020_CR60","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.mp.4001875","volume":"11","author":"MM Ryan","year":"2006","unstructured":"Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S (2006) Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 11:965\u2013978","journal-title":"Mol Psychiatry"},{"key":"8020_CR61","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0028-3908(97)00126-3","volume":"36","author":"L Vulchanova","year":"1997","unstructured":"Vulchanova L, Riedl MS, Shuster SJ, Buell G, Surprenant A, North RA, Elde R (1997) Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology 36:1229\u20131242","journal-title":"Neuropharmacology"},{"key":"8020_CR62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0074-7696(04)40002-3","volume":"240","author":"G Burnstock","year":"2004","unstructured":"Burnstock G, Knight GE (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240:31\u2013304","journal-title":"Int Rev Cytol"},{"key":"8020_CR63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0896-6273(02)00908-X","volume":"36","author":"RR Ji","year":"2002","unstructured":"Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36:57\u201368","journal-title":"Neuron"},{"key":"8020_CR64","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1038\/sj.emboj.7600893","volume":"24","author":"X Zhang","year":"2005","unstructured":"Zhang X, Huang J, McNaughton PA (2005) NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J 24:4211\u20134223","journal-title":"EMBO J"},{"key":"8020_CR65","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1523\/JNEUROSCI.0249-05.2005","volume":"25","author":"X Fang","year":"2005","unstructured":"Fang X, Djouhri L, McMullan S, Berry C, Okuse K, Waxman SG, Lawson SN (2005) TrkA is expressed in nociceptive neurons and influences electrophysiological properties via Nav1.8 expression in rapidly conducting nociceptors. J Neurosci 25:4868\u20134878","journal-title":"J Neurosci"},{"key":"8020_CR66","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1523\/JNEUROSCI.4015-06.2006","volume":"26","author":"F Amaya","year":"2006","unstructured":"Amaya F, Wang H, Costigan M, Allchorne AJ, Hatcher JP, Egerton J, Stean T, Morisset V, Grose D, Gunthorpe MJ, Chessell IP, Tate S, Green PJ, Woolf CJ (2006) The voltage-gated sodium channel Na(v)1.9 is an effector of peripheral inflammatory pain hypersensitivity. J Neurosci 26:12852\u201312860","journal-title":"J Neurosci"},{"key":"8020_CR67","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ncpneuro0639","volume":"3","author":"PJ Goadsby","year":"2007","unstructured":"Goadsby PJ (2007) Emerging therapies for migraine. Nat Clin Pract Neurol 3:610\u2013619","journal-title":"Nat Clin Pract Neurol"},{"key":"8020_CR68","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1523\/JNEUROSCI.0869-05.2005","volume":"25","author":"MJ Fischer","year":"2005","unstructured":"Fischer MJ, Koulchitsky S, Messlinger K (2005) The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus. J Neurosci 25:5877\u20135883","journal-title":"J Neurosci"},{"key":"8020_CR69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/187152707781387314","volume":"6","author":"L Edvinsson","year":"2007","unstructured":"Edvinsson L, Petersen KA (2007) CGRP-receptor antagonism in migraine treatment. CNS Neurol Disord Drug Targets 6:240\u2013246","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"8020_CR70","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1007\/s10072-007-0757-5","volume":"28","author":"S Benemei","year":"2007","unstructured":"Benemei S, Nicoletti P, Capone JA, Geppetti P (2007) Pain pharmacology in migraine: focus on CGRP and CGRP receptors. Neurol Sci 28:S89\u2013S93","journal-title":"Neurol Sci"},{"key":"8020_CR71","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2007.10.005","volume":"28","author":"H Doods","year":"2007","unstructured":"Doods H, Arndt K, Rudolf K, Just S (2007) CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci 28:580\u2013587","journal-title":"Trends Pharmacol Sci"},{"key":"8020_CR72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2005.12.001","volume":"27","author":"FF Hefti","year":"2006","unstructured":"Hefti FF, Rosenthal A, Walicke PA, Wyatt S, Vergara G, Shelton DL, Davies AM (2006) Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol Sci 27:85\u201391","journal-title":"Trends Pharmacol Sci"},{"key":"8020_CR73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.103.064907","volume":"310","author":"MF Jarvis","year":"2004","unstructured":"Jarvis MF, Bianchi B, Uchic JT, Cartmell J, Lee CH, Williams M, Faltynek C (2004) [3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2\/3 and P2X3 receptors. J Pharmacol Exp Ther 310:407\u2013416","journal-title":"J Pharmacol Exp Ther"},{"key":"8020_CR74","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3940(97)00456-4","volume":"229","author":"L Edvinsson","year":"1997","unstructured":"Edvinsson L, Cantera L, Jansen-Olesen I, Uddman R (1997) Expression of calcitonin gene-related peptide 1 receptor mRNA in human trigeminal ganglia and cerebral arteries. Neurosci Lett 229:209\u2013211","journal-title":"Neurosci Lett"},{"key":"8020_CR75","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00004647-200205000-00014","volume":"22","author":"KR Oliver","year":"2002","unstructured":"Oliver KR, Wainwright A, Edvinsson L, Pickard JD, Hill RG (2002) Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 22:620\u2013629","journal-title":"J Cereb Blood Flow Metab"},{"key":"8020_CR76","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0304-3959(94)00097-X","volume":"60","author":"M Fanciullacci","year":"1995","unstructured":"Fanciullacci M, Alessandri M, Figini M, Geppetti P, Michelacci S (1995) Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60:119\u2013123","journal-title":"Pain"},{"key":"8020_CR77","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1212\/WNL.55.9.1335","volume":"55","author":"M Ashina","year":"2000","unstructured":"Ashina M, Bendtsen L, Jensen R, Schifter S, Jansen-Olesen I, Olesen J (2000) Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology 55:1335\u20131340","journal-title":"Neurology"},{"key":"8020_CR78","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1526-4610.2004.04189.x","volume":"44","author":"P Sarchielli","year":"2004","unstructured":"Sarchielli P, Alberti A, Vaianella L, Pierguidi L, Floridi A, Mazzotta G, Floridi A, Gallai V (2004) Chemokine levels in the jugular venous blood of migraine without aura patients during attacks. Headache 44:961\u2013968","journal-title":"Headache"},{"key":"8020_CR79","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1468-2982.2006.01217.x","volume":"26","author":"M Alessandri","year":"2006","unstructured":"Alessandri M, Massanti L, Geppetti P, Bellucci G, Cipriani M, Fanciullacci M (2006) Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache. Cephalalgia 26:1287\u20131293","journal-title":"Cephalalgia"},{"key":"8020_CR80","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","volume":"22","author":"LH Lassen","year":"2002","unstructured":"Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54\u201361","journal-title":"Cephalalgia"},{"key":"8020_CR81","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.clpt.2004.10.001","volume":"77","author":"KA Petersen","year":"2005","unstructured":"Petersen KA, Lassen LH, Birk S, Lesko L, Olesen J (2005) BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 77:202\u2013213","journal-title":"Clin Pharmacol Ther"},{"key":"8020_CR82","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1468-2982.2005.00836.x","volume":"25","author":"G Juhasz","year":"2005","unstructured":"Juhasz G, Zsombok T, Jakab B, Nemeth J, Szolcsanyi J, Bagdy G (2005) Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide. (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 25:179\u2013183","journal-title":"Cephalalgia"},{"key":"8020_CR83","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1468-2982.2006.01133_1.x","volume":"26","author":"F Vanmolkot","year":"2006","unstructured":"Vanmolkot F, Van der Schueren B, de Hoon J (2006) Sumatriptan causes parallel decrease in plasma CGRP concentration and migraine headache during nitroglycerin-induced migraine attack. Cephalalgia 26:1037\u20131038","journal-title":"Cephalalgia"},{"key":"8020_CR84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(01)01532-1","volume":"434","author":"L Edvinsson","year":"2002","unstructured":"Edvinsson L, Alm R, Shaw D, Rutledge RZ, Koblan KS, Longmore J, Kane SA (2002) Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells. Eur J Pharmacol 434:49\u201353","journal-title":"Eur J Pharmacol"},{"key":"8020_CR85","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1468-2982.2004.00726.x","volume":"24","author":"M Iovino","year":"2004","unstructured":"Iovino M, Feifel U, Yong CL, Wolters JM, Wallenstein G (2004) Safety, tolerability and pharmacokinetics of BIBN 4096 BS., the first selective small molecule calcitonin gene-related peptide receptor antagonist., following single intravenous administration in healthy volunteers. Cephalalgia 24:645\u2013656","journal-title":"Cephalalgia"},{"key":"8020_CR86","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa030505","volume":"350","author":"J Olesen","year":"2004","unstructured":"Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM (2004) BIBN 4096 BS Clinical Proof of Concept Study Group. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104\u20131110","journal-title":"N Engl J Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-008-8020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-008-8020-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-008-8020-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:27:44Z","timestamp":1738204064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-008-8020-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["8020"],"URL":"https:\/\/doi.org\/10.1007\/s12035-008-8020-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}